Mounjaro®
Starting from £179.99/mo
Start journey Learn moreCough is not listed as a common side effect of semaglutide in UK prescribing information, but it does come up in patient reports often enough to be worth taking seriously. If you've started Wegovy and noticed a new dry cough or throat irritation, here's what we know, what might explain it, and how to decide whether yours needs attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The NHS medicines page for semaglutide sets out its recognised side-effect profile clearly. Nausea, vomiting, diarrhoea, constipation, stomach discomfort and fatigue lead the list. Cough does not appear there as a common or very common effect.
That matters, because it shapes the decision you're trying to make. A cough on semaglutide is not the same as a cough on an ACE inhibitor, where you'd expect it as a direct pharmacological effect in roughly one in ten users. If you want to explore this question in more detail, our page looking at whether Wegovy can cause a cough walks through the evidence behind that distinction. With semaglutide, if a cough has appeared, the question is whether it's related to treatment at all — and if so, through which route.
The answer is usually indirect. Semaglutide slows gastric emptying and reduces appetite partly by acting on GI motility. For some people, this tips them towards acid reflux or worsens existing reflux, and reflux can cause exactly the kind of persistent throat-clearing, tickle or dry cough that patients describe. It's a GI side effect presenting in an unexpected place, not a direct respiratory one.
If you're finding this kind of information useful and want to read more about how semaglutide works as a treatment, there's a fuller overview available.
This is the factor most worth ruling out first, and it's the one many patients don't think of immediately. ACE inhibitors (lisinopril, ramipril, perindopril and others) are very commonly prescribed for high blood pressure and heart conditions. A dry, irritating cough is a recognised effect of this drug class in a meaningful proportion of users.
High blood pressure is also one of the weight-related conditions that makes someone eligible for semaglutide in the first place under UK licensing. So ACE inhibitor use and Wegovy use overlap considerably in the real-world patient population. If you're on both, the ACE inhibitor is statistically the more probable cause of a cough.
The same logic applies to other medicines that occasionally cause cough: certain antihistamines at high doses, inhaled steroids, beta-blockers in some people. A full medication review with your prescriber or GP is the right move, not assuming the newest medicine is always the culprit.
If you're unsure what medicines interact with semaglutide more broadly, our page on pain relievers and semaglutide covers some of the combination questions our prescribers hear regularly.
Gastro-oesophageal reflux disease, or GORD, involves stomach acid travelling back up the oesophagus. It's more common in people with higher BMI (another overlap with the Wegovy population) and can worsen early in treatment as the GI system adjusts. Slowed gastric emptying, which GLP-1 medicines produce, can in some people increase the amount of time food and acid sit near the lower oesophageal sphincter.
The result can be a cough that is worse lying down, worse after eating, or worse at night. Some people describe it as a constant need to clear their throat rather than a productive cough. It's sometimes called 'silent reflux' because the heartburn sensation isn't always obvious.
Practical steps that often help: eating smaller portions (the reduced appetite most people feel on semaglutide naturally supports this), avoiding lying down for two to three hours after eating, reducing caffeine and fatty foods, and staying well hydrated. If reflux symptoms are significant, a prescriber may consider whether an antacid or proton pump inhibitor is appropriate alongside treatment.
Understanding the full picture of Wegovy as a treatment (including how GI effects are managed) can help set realistic expectations during the adjustment period.
Most new coughs that begin shortly after starting semaglutide, and that fit the reflux or throat-irritation pattern, settle within two to four weeks as the body adapts. Our guide to semaglutide as a medicine covers the dose escalation schedule in detail, which can help you identify whether your symptoms align with a particular stage of treatment. If yours started when you moved to a higher dose, the same pattern often applies, the system needs time to calibrate.
Get medical help sooner if the cough is accompanied by chest pain, shortness of breath, wheezing, fever, or if you're coughing up blood or discoloured mucus. These are not semaglutide side effects and need prompt clinical assessment regardless of what else you're taking.
Also report it promptly if the cough is severe enough to disrupt sleep or daily life and shows no sign of settling. The MHRA's Yellow Card scheme exists so that patients and clinicians can flag unexpected effects, reporting your experience contributes to post-market safety monitoring, which is particularly valuable for newer medicines under active surveillance.
Our dedicated page on Wegovy and cough goes further into the reflux mechanism and how to distinguish the different patterns. If you're managing other symptoms alongside this, our general FAQs may answer some of those questions too.
If you're considering starting Wegovy and want to understand whether it's right for your situation, a free consultation with one of our prescribers is a sensible next step. Check your eligibility and our clinical team will review your case the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.